A major emerging challenge to resolution of a stable phylogenetic Tree of Life has been incongruent inference among studies. Given the increasing ubiquity of incongruent studies, analyzing the predicted phylogenetic utility and quantitative evidence regarding contributions toward resolution of commonly-used markers in historical studies over the last decade represents an important, yet neglected, component of phylogenetics. Here we examine the phylogenetic utility of two sets of commonly-used legacy markers for understanding the evolutionary relationships among goodeines, a group of viviparous freshwater fishes endemic to central Mexico. Our analyses reveal that the validity of existing inferences is compromised by both lack of information and substantially biased patterns of nucleotide substitution. Our analyses demonstrate that many of the evolutionary relationships of goodeines remain uncertain - despite over a century of work. Our results provide an updated baseline of critically needed areas of investigation for the group and underscore the importance of quantifying phylogenetic information content as a fundamental step towards eroding false confidence in results based on weak and biased evidence.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ympev.2019.01.025DOI Listing

Publication Analysis

Top Keywords

phylogenetic utility
8
evolutionary relationships
8
relationships goodeines
8
assessing phylogenetic
4
phylogenetic reveal
4
reveal uncertainty
4
uncertainty historical
4
historical data
4
data example
4
example goodeinae
4

Similar Publications

Global epidemiology of Mycobacterium tuberculosis lineage 4 insights from Ecuadorian genomic data.

Sci Rep

January 2025

Laboratorio de Interacciones Hospedero-Patógeno, Unidad de Biología Molecular, Institut Pasteur de Montevideo, Montevideo, Uruguay.

Tuberculosis is a global public health concern, and understanding Mycobacterium tuberculosis transmission routes and genetic diversity of M. tuberculosis is crucial for outbreak control. This study aimed to explore the genomic epidemiology and genetic diversity of M.

View Article and Find Full Text PDF

Russia is a country with a high incidence of tick-borne encephalitis (TBE). In northwestern regions of Russia, 110 TBE cases were registered in 2021. The largest numbers of TBE cases were registered in the Arkhangelsk region and St.

View Article and Find Full Text PDF

Genomic data on from the African continent are currently lacking, resulting in the region being under-represented in global analyses of infection (CDI) epidemiology. For the first time in Nigeria, we utilized whole-genome sequencing and phylogenetic tools to compare isolates from diarrhoeic human patients (=142), livestock (=38), poultry manure (=5) and dogs (=9) in the same geographic area (Makurdi, north-central Nigeria) and relate them to the global population. In addition, selected isolates were tested for antimicrobial susceptibility (=33) and characterized by PCR ribotyping (=53).

View Article and Find Full Text PDF

sp. nov., a new hyphomycete from desertified rocky soil in southwest China.

Int J Syst Evol Microbiol

January 2025

Laboratory for Conservation and Utilization of Bio-Resources, Key Laboratory for Microbial Resources of the Ministry of Education, Yunnan University, Kunming 650091, Yunnan, PR China.

Two strains of , identified based on morphology and phylogenetic analysis, were isolated from rocky desertification soils in Yunnan province. Phylogenetic analyses inferred from three loci (the internal transcribed spacer of the nuclear ribosomal RNA gene, β-tubulin and RNA polymerase II second-largest subunit) showed that the two strains formed a single clade and were introduced as a new species of , is characterized by having ampulliform or broadly fusiform conidiogenous cells and dark olivaceous-green, oblong-ellipsoidal conidia. Phylogenetically, is most closely related to , but it distinguishes the latter by longer and narrower conidia.

View Article and Find Full Text PDF

Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda.

J Antimicrob Chemother

January 2025

Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA.

Background: Lenacapavir, a novel HIV-1 capsid inhibitor, shows promise for treating MDR HIV-1, as well as for pre-exposure prophylaxis (PrEP) in prevention of HIV infection. Its unique mechanism and lack of cross-resistance with other antiretroviral classes make lenacapavir a significant addition to HIV therapy. The clinical trials CALIBRATE and CAPELLA have demonstrated high viral suppression rates in both ART-naive individuals and individuals with MDR HIV-1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!